Fundraising Fox

Biofrontera

NASDAQ: BFRI

Woburn, US · Delaware corporation

Biotech

Founders & leadership

HL
Hermann LuebbertExecutive Officer, Director
EF
Eugene Frederick Leffler, IIIExecutive Officer
EF
Erica F GatesExecutive Officer
JJ
John J III BorerDirector
LM
Loretta M WedgeDirector
EL
Erica L MonacoExecutive Officer
JJ
John J. Borer IIIDirector
BH
Beth HoffmanDirector
HL
Heikki LanckrietDirector
KD
Kevin D. WeberDirector

Reported raises · per SEC filings

Form D private placements
▶$11MraisedJul 2025 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Beth HoffmanDirector
  • John J. Borer IIIDirector
  • Hermann LuebbertExecutive Officer, Director
  • Eugene Frederick Leffler, IIIExecutive Officer
  • Heikki LanckrietDirector
  • Kevin D. WeberDirector
Offering amount
$11M
Amount sold
$11M
First sale
Jun 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.2MraisedDec 2024 · 5 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John J. Borer IIIDirector
  • Beth HoffmanDirector
  • Hermann LuebbertExecutive Officer, Director
  • Heikki LanckrietDirector
  • Eugene Frederick Leffler, IIIExecutive Officer
  • Kevin D. WeberDirector
Offering amount
$4.2M
Amount sold
$4.2M
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8MraisedMar 2024 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin D. WeberDirector
  • John J. Borer IIIDirector
  • Eugene Frederick Leffler, IIIExecutive Officer
  • Hermann LuebbertExecutive Officer, Director
  • Beth HoffmanDirector
  • Heikki LanckrietDirector
Offering amount
$8M
Amount sold
$8M
Sales commissions
$685K
Placement agents
Roth Capital Partners, LLC
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.7MraisedNov 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • John J III BorerDirector
  • Kevin D WeberDirector
  • Hermann LuebbertExecutive Officer, Director
  • Erica F GatesExecutive Officer
  • Erica L MonacoExecutive Officer
  • Eugene Frederick LefflerExecutive Officer
  • Loretta M WedgeDirector
  • Beth J HoffmanDirector
Offering amount
$3.7M
Amount sold
$3.7M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.1MraisedAug 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Erica L MonacoExecutive Officer
  • Hermann LuebbertExecutive Officer, Director
  • Beth J HoffmanDirector
  • Kevin D WeberDirector
  • John J III BorerDirector
  • Loretta M WedgeDirector
  • Erica F GatesExecutive Officer
Offering amount
$7.1M
Amount sold
$7.1M
First sale
Jul 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.4MraisedMay 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin D WeberDirector
  • Loretta M WedgeDirector
  • Erica L MonacoExecutive Officer
  • Beth J HoffmanDirector
  • John J III BorerDirector
  • Hermann LuebbertExecutive Officer, Director
  • Erica F GatesExecutive Officer
Offering amount
$9.4M
Amount sold
$9.4M
Sales commissions
$660.1K
Placement agents
The Benchmark Company, LLC, Roth Capital Partners, LLC
First sale
May 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15MraisedDec 2021 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Erica F GatesExecutive Officer
  • John J III BorerDirector
  • Beth J HoffmanDirector
  • Hermann LuebbertExecutive Officer, Director
  • Loretta M WedgeDirector
  • Erica L MonacoExecutive Officer
Offering amount
$15M
Amount sold
$15M
Sales commissions
$1.2M
Placement agents
Roth Capital Partners, LLC, The Benchmark Company, LLC
First sale
Nov 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.